A new immune-modulating treatment has shown promising results for treating moderate to severe eczema, delivering fast itch ...

Arcutis Biotherapeutics has enrolled the first child in an open-label Phase II trial of Zoryve (roflumilast) for atopic dermatitis.

Medically reviewed by William Truswell, MD Eczema is a long-term condition where an overactive immune response causes skin inflammation (swelling) and irritation. Eczema leads to dry, itchy patches of ...

I’ve had to learn that just because I don’t have eczema myself, it doesn’t mean I can remain ignorant about it and the effect it has on my kids. Not if I want to help them.

The 2016 Children with Eczema, Antibiotic Management (CREAM) randomised controlled trial included 113 children with mild to moderate eczema and a suspected infection (not a severe infection). The ...

If you’re looking for an eczema treatment, the right lotion can help you find some relief. Shop the best eczema lotions from CeraVe, Aveeno, Vanicream and more.

Nektar Therapeutics shares doubled in early trading Tuesday after the U.S. biotech firm said it reached its targets in a ...

Eczema may occur after the third month of life as a weepy rash on the face and outer surfaces of the arms and legs. In later childhood it becomes a dry, scaly, itchy rash in the inner creases of the ...